The current role of high-intensity focused ultrasound for the management of radiation-recurrent prostate cancer

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA. Cancer J. Clin. 59(4), 225–249 (2009).
   PubMed Web of Science ®Google Scholar
• Schröder FH, Hugosson J, Roobol MJ et al.; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360(13), 1320–1328 (2009).
   PubMed Web of Science ®Google Scholar
• Bill-Axelson A, Holmberg L, Filén F et al.; Scandinavian Prostate Cancer Group Study Number 4. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J. Natl Cancer Inst. 100(16), 1144–1154 (2008).
   PubMed Web of Science ®Google Scholar
• Bastian PJ, Mangold LA, Epstein JI, Partin AW. Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer 101(9), 2001–2005 (2004).
   PubMed Web of Science ®Google Scholar
• Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schröder FH. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J. Urol. 177(1), 107–112; discussion 112 (2007).
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Bellmunt J, Bolla M et al.; European Association of Urology. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur. Urol. 59(1), 61–71 (2011).
   PubMed Web of Science ®Google Scholar
• Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J. Clin. Oncol. 22(11), 2141–2149 (2004).
   PubMed Web of Science ®Google Scholar
• Klotz L. Active surveillance for prostate cancer: for whom? J. Clin. Oncol. 23(32), 8165–8169 (2005).
   PubMed Web of Science ®Google Scholar
• Lu-Yao GL, Albertsen PC, Moore DF et al. Outcomes of localized prostate cancer following conservative management. JAMA 302(11), 1202–1209 (2009).
   PubMed Web of Science ®Google Scholar
• Dall’Era MA, Cooperberg MR, Chan JM et al. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer 112(8), 1650–1659 (2008).
   PubMed Web of Science ®Google Scholar
• Chaussy C, Thüroff S, Rebillard X, Gelet A. Technology insight: high-intensity focused ultrasound for urologic cancers. Nat. Clin. Pract. Urol. 2(4), 191–198 (2005).
   PubMedGoogle Scholar
• Beerlage HP, van Leenders GJ, Oosterhof GO et al. High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study. Prostate 39(1), 41–46 (1999).
   PubMed Web of Science ®Google Scholar
• Warmuth M, Johansson T, Mad P. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer. Eur. Urol. 58(6), 803–815 (2010).
   PubMed Web of Science ®Google Scholar
• Illing R, Emberton M. Sonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer. Expert Rev. Med. Devices 3(6), 717–729 (2006).
   PubMed Web of Science ®Google Scholar
• Barkin J. HIFU: definitely ready for prime time. Can. Urol. Assoc. J. 5(6), 422–423 (2011).
   PubMed Web of Science ®Google Scholar
• Illing R, Chapman A. The clinical applications of high intensity focused ultrasound in the prostate. Int. J. Hyperthermia 23(2), 183–191 (2007).
   PubMed Web of Science ®Google Scholar
• Uchida T, Sanghvi NT, Gardner TA et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology 59(3), 394–398; discussion 398 (2002).
   PubMed Web of Science ®Google Scholar
• Inoue Y, Goto K, Hayashi T, Hayashi M. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer. Int. J. Urol. 18(5), 358–362 (2011).
   PubMed Web of Science ®Google Scholar
• Uchida T, Shoji S, Nakano M et al. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Int. J. Urol. 16(11), 881–886 (2009).
   PubMed Web of Science ®Google Scholar
• Rebillard X, Soulié M, Chartier-Kastler E et al.; Association Francaise d’Urologie. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int. 101(10), 1205–1213 (2008).
   PubMed Web of Science ®Google Scholar
• Blana A, Rogenhofer S, Ganzer R et al. Eight years’ experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. Urology 72(6), 1329–1333; discussion 1333 (2008).
   PubMed Web of Science ®Google Scholar
• Poissonnier L, Chapelon JY, Rouvière O et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur. Urol. 51(2), 381–387 (2007).
   PubMed Web of Science ®Google Scholar
• Blana A, Brown SC, Chaussy C et al. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int. 104(8), 1058–1062 (2009).
   PubMed Web of Science ®Google Scholar
• Ganzer R, Rogenhofer S, Walter B et al. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. Eur. Urol. 53(3), 547–553 (2008).
   PubMed Web of Science ®Google Scholar
• Thüroff S, Chaussy C, Vallancien G et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J. Endourol. 17(8), 673–677 (2003).
   PubMed Web of Science ®Google Scholar
• Lukka H, Waldron T, Chin J et al.; Genitourinary Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. High-intensity focused ultrasound for prostate cancer: a systematic review. Clin. Oncol. (R. Coll. Radiol). 23(2), 117–127 (2011).
   PubMed Web of Science ®Google Scholar
• Blana A, Murat FJ, Walter B et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur. Urol. 53(6), 1194–1201 (2008).
   PubMed Web of Science ®Google Scholar
• Challacombe BJ, Murphy DG, Zakri R, Cahill DJ. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up. BJU Int. 104(2), 200–204 (2009).
   PubMed Web of Science ®Google Scholar
• Tsakiris P, Thüroff S, de la Rosette J, Chaussy C. Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence. J. Endourol. 22(2), 221–229 (2008).
   PubMed Web of Science ®Google Scholar
• Ahmed HU, Zacharakis E, Dudderidge T et al. High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br. J. Cancer 101(1), 19–26 (2009).
   PubMed Web of Science ®Google Scholar
• Zietman AL, Bae K, Slater JD et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College Of Radiology 95-09. J. Clin. Oncol. 28(7), 1106–1111 (2010).
   PubMed Web of Science ®Google Scholar
• D’Amico AV, Chen MH, Renshaw AA, Loffredo B, Kantoff PW. Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy. J. Clin. Oncol. 26(18), 2979–2983 (2008).
   PubMed Web of Science ®Google Scholar
• Chalasani V, Martinez CH, Lim D, Chin J. Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis. 12(2), 124–129 (2009).
   PubMed Web of Science ®Google Scholar
• Asimakopoulos AD, Miano R, Virgili G, Vespasiani G, Finazzi Agrò E. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Urol. Oncol. doi:10.1016/j.urolonc.2010.08.019 (2011) (Epub ahead of print).
   Google Scholar
• Hayashi M, Shinmei S, Asano K. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy. Int. J. Urol. 14(11), 1048–1050 (2007).
   PubMed Web of Science ®Google Scholar
• Uchida T, Shoji S, Nakano M et al. High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy. BJU Int. 107(3), 378–382 (2011).
   PubMed Web of Science ®Google Scholar
• Gelet A, Chapelon JY, Poissonnier L et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 63(4), 625–629 (2004).
   PubMed Web of Science ®Google Scholar
• Murat FJ, Poissonnier L, Rabilloud M et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur. Urol. 55(3), 640–647 (2009).
   PubMed Web of Science ®Google Scholar
• Giovanessi L, Peroni A, Mirabella G et al. High-intensity focused ultrasound (HIFU): our experience in the treatment of prostate cancer relapsing after radiotherapy. Urologia 78(3), 180–183 (2011).
   PubMedGoogle Scholar
• Zacharakis E, Ahmed HU, Ishaq A et al. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int. 102(7), 786–792 (2008).
   PubMed Web of Science ®Google Scholar
• Ahmed HU, Cathcart P, Chalasani V et al. Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy. Cancer 118(12), 3071–3078 (2011).
   PubMed Web of Science ®Google Scholar
• Berge V, Baco E, Dahl AA, Karlsen SJ. Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer. Int. J. Urol. 18(9), 646–651 (2011).
   PubMed Web of Science ®Google Scholar
• Netsch C, Bach T, Gross E, Gross AJ. Rectourethral fistula after high-intensity focused ultrasound therapy for prostate cancer and its surgical management. Urology 77(4), 999–1004 (2011).
   PubMed Web of Science ®Google Scholar
• Berge V, Baco E, Karlsen SJ. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results. Scand. J. Urol. Nephrol. 44(4), 223–227 (2010).
   PubMed Web of Science ®Google Scholar
• Ahmed HU, Ishaq A, Zacharakis E et al. Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy. BJU Int. 103(3), 321–323 (2009).
   PubMed Web of Science ®Google Scholar